1
Clinical Trials associated with Malaria vaccine (PfPEBS) (Vac4All) / Unknown statusPhase 1/2 Phase I and IIa Trial for Assessment of Safety, Immunogenicity (Phase Ia) and Efficacy (Phase IIa) Against Sporozoite Challenge of P. Falciparum Pre-Erythrocytic and Blood Stage (PfPEBS-LSP) Malaria Vaccine Candidate
This study intends to test the hypothesis that the malaria antigen PfPEBS, manufactured as a synthetic protein and adjuvanted with aluminium hydroxide will be well-tolerated and immunogenic (Phase 1), functionally active against the erythrocytic stages (Phase 1) and efficacious (Phase 2) against the pre-erythrocytic stages in protecting against an artificial malaria challenge using Pf sporozoites in a healthy adult population.
100 Clinical Results associated with Malaria vaccine (PfPEBS) (Vac4All)
100 Translational Medicine associated with Malaria vaccine (PfPEBS) (Vac4All)
100 Patents (Medical) associated with Malaria vaccine (PfPEBS) (Vac4All)
100 Deals associated with Malaria vaccine (PfPEBS) (Vac4All)